Baclofen tablets are taken by mouth in individually adjusted doses to reduce painful muscle stiffness and spasms. They are prescribed mainly for spasticity linked to multiple sclerosis, spinal-cord…
Baclofen tablets are taken by mouth in individually adjusted doses to reduce painful muscle stiffness and spasms. They are prescribed mainly for spasticity linked to multiple sclerosis, spinal-cord injury, cerebral disorders, or other neurological disease.
Baclofen is a centrally acting skeletal muscle relaxant. Its active ingredient is baclofen, a selective agonist of gamma-aminobutyric acid type B receptors, known as GABA-B receptors. These receptors are found in the central nervous system, including the spinal cord.
Baclofen is usually prescribed for adults with spasticity caused by multiple sclerosis, spinal-cord disease, brain injury, cerebral palsy, or other neurological conditions. The UK product information and regulatory material reviewed through the MHRA describe oral baclofen as a treatment requiring gradual dose adjustment because the useful dose differs substantially between patients [1].
Common clinical indications include:
Baclofen is prescribed for neurological spasticity rather than ordinary muscle soreness after exercise. Its benefit depends on the cause of the muscle tightness, the severity of symptoms, kidney function, and sensitivity to sedation.
The product is supplied as oral tablets containing baclofen. The tablet form is swallowed with water, and the amount taken at each intake is selected individually rather than being one fixed dose for every patient.
Commercial naming can vary between manufacturers and markets, while the clinically relevant substance remains baclofen. The strength and schedule must be matched to the individual prescription. A patient changing between products should keep the same prescribed active ingredient and follow the new product’s authorised instructions.
The therapeutic action comes from baclofen itself. Tablet colour, shape, and markings do not determine the correct dose.
By stimulating GABA-B receptors, baclofen reduces the release of excitatory neurotransmitters. This suppresses both monosynaptic and polysynaptic reflexes at spinal-cord level. In practical terms, fewer abnormal nerve signals reach the muscles, so spasms become less frequent and muscle tone falls.
The effect is different from that of a simple painkiller. Baclofen acts on the neurological pathway producing spasticity rather than only reducing the sensation of pain.
Baclofen is started at a low individually selected dose and increased gradually when needed. The purpose of titration is to find the smallest amount that reduces spasticity without causing disabling drowsiness, dizziness, weakness, or confusion.
The usual administration principles are:
A prescriber may adjust the schedule over several days or longer. The final daily amount depends on response and tolerability. Older adults and people with reduced kidney function often require more cautious adjustment because baclofen is cleared mainly through the kidneys. Kidney function may change during illness or dehydration. Follow-up checks can help identify accumulation before severe toxicity develops.
Tablets should be taken exactly as prescribed. Crushing, splitting, or altering a tablet is appropriate only when the specific tablet design allows it and the prescriber or dispensing instructions support that method.
Baclofen is one option for neurological spasticity. The best choice depends on the distribution of stiffness, muscle strength, kidney and liver function, sedation risk, and the person’s rehabilitation goals.
| Treatment approach | Main action | Main limitation |
|---|---|---|
| Baclofen | GABA-B receptor activation reduces spinal reflex activity | Drowsiness, weakness, and withdrawal risk |
| Tizanidine | Reduces excitatory signalling through alpha-2 receptor activity | Sedation, low blood pressure, and liver-monitoring considerations |
| Dantrolene | Acts directly within skeletal muscle to reduce contraction | Muscle weakness and liver-related precautions |
Baclofen may suit widespread spasticity because it acts within the central nervous system. Tizanidine can be considered when a different central mechanism is preferred, while dantrolene acts directly on muscle and may be selected in specific circumstances.
These treatments are not interchangeable milligram for milligram. A switch requires a new dose plan. Combining muscle relaxants can increase weakness and sedation without producing a proportional improvement in function.
Several practical errors can reduce benefit or create avoidable harm:
One detail patients often miss is the role of treatment timing. A dose that is helpful at night may cause unacceptable impairment before work or physiotherapy. Recording the timing of both spasms and side effects gives the prescriber information for a more useful schedule.
Extra caution and individual dose adjustment are needed with:
Kidney impairment is a major clinical concern. Baclofen can accumulate when renal clearance is reduced, leading to encephalopathy, profound drowsiness, confusion, or coma even at doses tolerated by people with normal kidney function. The MHRA has highlighted the need for caution with baclofen in people at risk of renal impairment [3].
Baclofen is not suitable for everyone. NOT for you if you have previously had a serious allergic reaction to baclofen or one of the tablet ingredients.
The most common adverse effects are related to reduced activity in the central nervous system. They often appear during dose increases and may improve when the dose is held or adjusted.
Possible effects include:
The NHS describes drowsiness, nausea, and dizziness among the recognised effects of baclofen, with symptoms more likely when treatment begins or the dose rises [2]. A person who feels sleepy should avoid driving, cycling on public roads, operating machinery, or making safety-critical decisions until the response is clear.
A practical problem is that baclofen can reduce spasticity and useful muscle support at the same time. Someone who relies on stiffness to stand or transfer may feel weaker even when the spasms improve. This is a reason to report a change in walking, balance, or transfers promptly.
Rare but serious reactions include severe confusion, hallucinations, breathing difficulty, fainting, profound weakness, or an allergic reaction with swelling of the lips, tongue, or throat. Severe sedation is more likely when baclofen is combined with alcohol, opioids, sleeping tablets, or medicines used for anxiety.
Some patients notice nausea when starting treatment. Taking the tablet with a meal can help, but persistent vomiting, severe abdominal symptoms, or inability to keep fluids down needs prompt medical assessment.
In clinical practice, baclofen is usually approached as a titration exercise rather than a one-time treatment. Doctors often aim for a noticeable reduction in spasms while preserving enough muscle strength for walking, transfers, and rehabilitation.
A useful response may be gradual. Some people notice less night-time spasm first, while others gain better range of movement before pain improves. Lack of benefit after a carefully adjusted trial can lead to a review of the diagnosis, physiotherapy plan, dose timing, or alternative antispasticity treatment.
Clinicians also assess function, not only symptom scores. A lower spasm count is not a complete success if the person becomes too weak to stand. The balance between tone and strength is central to prescribing.
Older adults need special attention because sedation, dizziness, kidney impairment, and falls can occur together. The EMA’s safety information for centrally acting medicines supports careful review of renal function and central nervous system effects when baclofen is used in vulnerable patients [4].
Baclofen can have stronger sedative and breathing-suppressing effects when combined with opioids, benzodiazepines, sleeping tablets, or other central nervous system depressants. The NHS describes drowsiness as a common concern and advises caution with substances that impair alertness. Clinical review by a prescriber is needed before combining these medicines, especially in 2026 treatment plans involving several sedating drugs. The FDA prescribing information also warns about additive central nervous system depression.
The dose should not be increased independently when spasms remain troublesome. A clinician may assess adherence, timing, kidney function, the cause of spasticity, physiotherapy goals, and whether another treatment is more suitable. NHS guidance from 2024 supports dose adjustment according to response and tolerability rather than using one fixed amount for everyone. Persistent symptoms after a properly managed trial should lead to a treatment review, not repeated extra doses.
Gentle stretching, prescribed physiotherapy, regular sleep, hydration, and a consistent daily routine may support functional goals alongside baclofen. Alcohol can worsen sedation and coordination, while dehydration or skipped meals may make dizziness feel worse. The NHS guidance from 2024 links baclofen use with drowsiness and dizziness, so exercise should be adapted when balance or strength changes. A physiotherapist can help distinguish reduced spasm from excessive weakness during rehabilitation.
Regular baclofen should usually be reduced gradually rather than stopped suddenly. Abrupt withdrawal can cause rebound spasticity, agitation, hallucinations, fever, seizures, and severe neurological deterioration. The MHRA safety information from 2019 identifies withdrawal as a clinically significant risk requiring planned reduction. A tapering schedule depends on treatment duration, daily amount, neurological condition, and current symptoms.
Older adults can use baclofen in selected situations, but treatment usually begins cautiously because sedation, falls, confusion, and reduced kidney clearance are more likely. The EMA information and UK prescribing information dated 2018 support careful dose selection and monitoring in people with renal impairment. A new problem with balance, alertness, urination, or muscle strength can indicate that the dose needs review. Older patients should also avoid combining baclofen with alcohol or other sedating medicines unless the combination has been specifically assessed.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 3 reviews
The night spasms eased first, and I slept better. I felt groggy after the early doses, so I avoided driving until that settled. The improvement was useful, but it took gradual adjustments.
Norwich Several weeks 30 Sept 2026The spasms became less painful, but I disliked the heavy legs and dizziness when standing. Taking it with a meal helped my stomach. The dose had to be reduced because walking felt less steady.
Southampton Several weeks 14 Oct 2026Baclofen reduced the sudden leg tightening after about a short treatment period. I missed a dose once and took two together, which made me very sleepy. After that, I kept the schedule written down and did not repeat the mistake.
Portsmouth A short treatment period 29 Oct 2026
